ALX Oncology Holdings Inc (ALXO)
NASDAQ
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -311.752 | -213.104 | -22.807 | -20.451 | -35.965 | -58.577 |
Return on Equity (%) | 67.218 | 38.019 | -28.364 | -21.053 | -39.419 | -70.968 |
Return on Invested Capital (%) | -299.924 | -268.901 | -20.187 | -21.31 | -42.428 | -84.65 |
Operating Margin (%) | -662.119 | -400.083 | -3780.711 | N/A | N/A | N/A |
Net Profit Margin (%) | -841.896 | -485.217 | -4309.814 | N/A | N/A | N/A |
Book Value Per Share | 0.44 | -0.013 | 10.788 | 8.945 | 6.448 | 3.808 |
Earnings Per Share | -0.836 | -1.118 | -1.279 | -2.056 | -3.022 | -3.228 |
Cash Per Share | 0.397 | 0.433 | 10.898 | 8.96 | 1.195 | 0.45 |
Working Capital Per Share | 0.401 | 0.232 | 10.786 | 8.666 | 5.938 | 3.064 |
Operating Profit Per Share | 0.03 | 0.042 | 0.008 | N/A | N/A | N/A |
EBIT Per Share | -0.658 | -0.923 | -1.142 | -2.057 | -3.02 | -3.228 |
EBITDA Per Share | -0.658 | -0.923 | -1.142 | -2.057 | -3.02 | -3.228 |
Free Cash Flow Per Share | -0.826 | -1.122 | -1.283 | -1.936 | -2.995 | -3.219 |
Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 20,81M | 20,81M | 39,85M | 40,59M | 40,86M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
Actions en circulation | 40,86M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 85,97M |
Ratio cours/bénéfice | -0,5 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 3,55 |
Ratio prix/valeur comptable | 0,42 |
Rendement de dividende | - |
Actions en circulation | 52,74M |
Volume moyen (1 semaine) | 1,19M |
Volume moyen (1 mois) | 834,03k |
Variation sur 52 semaines | -89,30% |
Plus haut sur 52 semaines | 17,825 |
Plus bas sur 52 semaines | 1,19 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales